Piper Sandler & Co’s Tandem Diabetes Care TNDM Stock Holding History

Piper Sandler & Co’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,523	Closed	-$6K	–	17
2017 Q4	$6K	Buy	+2,523	New	+$7.92K	0.01%	14
2015 Q4	–	Sell	-3,700	Closed	-$326K	–	67
2015 Q3	$326K	Buy	+3,700	New	+$431K	0.35%	34
2015 Q2	–	Sell	-4,500	Closed	-$568K	–	116
2015 Q1	$568K	Buy	4,500 +1,500	+50%	+$195K	0.24%	40
2014 Q4	$381K	Buy	3,000 +970	+48%	+$134K	0.19%	37
2014 Q3	$272K	Buy	+2,030	New	+$284K	0.14%	64

Other funds holding TNDM

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Piper Sandler & Co's TNDM Position: Q1 2018 in Review

Piper Sandler & Co sold out of Tandem Diabetes Care (TNDM) in Q1 2018, closing a stake of 2,523 shares — an estimated $6K sold.

Piper Sandler & Co first reported a position in TNDM in Q3 2014 and held it in 5 quarters. The position peaked at $568K in Q1 2015. 75 funds tracked by Wall St. Rank hold TNDM as of Q1 2018.

Piper Sandler & Co reported no remaining Tandem Diabetes Care position as of Q1 2018 after selling out during the quarter.
Piper Sandler & Co sold 2,523 Tandem Diabetes Care shares in Q1 2018, an estimated $6K.
Piper Sandler & Co first reported a position in Tandem Diabetes Care in Q3 2014 and held it in 5 quarters.
Piper Sandler & Co's Tandem Diabetes Care position peaked at $568K in Q1 2015.
75 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2018.

Based on Piper Sandler & Co's 13F filing for Q1 2018, filed 15 May 2018.